Sarder TV
Sarder TV
You are at:»»Exclusive: Thoughts on the Mylan and the Epipen debacle

Exclusive: Thoughts on the Mylan and the Epipen debacle

0
By on Case Study, Learning from the Best, Sarder Author Talks
Showing 1 of 1

Baruch Lev (Author & Professor, NYU Stern School of Business)


Baruch Lev talks about the recent scandal concerning the disturbingly high increase in the cost of the EpiPen product. He explains how his recommended accounting changes would likely have caught the increase much sooner than happened with this product. He discusses why it is important to be able to break revenue out by product to get a fuller picture of a company.

Share.

About Author

Baruch Lev

Author & Professor, NYU Stern School of Business

Baruch Lev is the Philip Bardes Professor of Accounting and Finance at New York University Stern School of Business. Professor Lev has been with NYU for 17 years. His primary research areas of interest include corporate governance; earnings management; financial accounting; financial statement analysis; intangible assets/intellectual capital; capital markets; and mergers and acquisitions. Professor Lev is the author of six books, including the most recent: The End of Accounting, published in 2016. Professor Lev has received numerous awards and prizes, including two honorary doctorates.

Associated Organizations


Interviewed By


Tracey Fitzpatrick

Tracey Fitzpatrick

Sarder TV Anchor & Former Market News Video Anchor

Related Posts

Leave A Reply